37 CFR Appendix B to Subpart G of Part 1 - Appendix B to Subpart G of Part 1—List of Modified Nucleotides

Appendix B to Subpart G of Part 1—List of Modified Nucleotides

Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).

Symbol Meaning
ac4c 4-acetylcytidine.
chm5u 5-(carboxyhydroxymethyl)uridine.
cm 2′-O-methylcytidine.
cmnm5s2u 5-carboxymethylaminomethyl-2-thiouridine.
cmnm5u 5-carboxymethylaminomethyluridine.
d dihydrouridine.
fm 2′-O-methylpseudouridine.
gal q beta, D-galactosylqueuosine.
gm 2′-O-methylguanosine.
i inosine.
i6a N6-isopentenyladenosine.
m1a 1-methyladenosine.
m1f 1-methylpseudouridine.
m1g 1-methylguanosine.
m1i 1-methylinosine.
m22g 2,2-dimethylguanosine.
m2a 2-methyladenosine.
m2g 2-methylguanosine.
m3c 3-methylcytidine.
m5c 5-methylcytidine.
m6a N6-methyladenosine.
m7g 7-methylguanosine.
mam5u 5-methylaminomethyluridine.
mam5s2u 5-methoxyaminomethyl-2-thiouridine.
man q beta, D-mannosylqueuosine.
mcm5s2u 5-methoxycarbonylmethyl-2-thiouridine.
mcm5u 5-methoxycarbonylmethyluridine.
mo5u 5-methoxyuridine.
ms2i6a 2-methylthio-N6-isopentenyladenosine.
ms2t6a N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine.
mt6a N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine.
mv uridine-5-oxyacetic acid-methylester.
o5u uridine-5-oxyacetic acid.
osyw wybutoxosine.
p pseudouridine.
q queuosine.
s2c 2-thiocytidine.
s2t 5-methyl-2-thiouridine.
s2u 2-thiouridine.
s4u 4-thiouridine.
t 5-methyluridine.
t6a N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine.
tm 2′-O-methyl-5-methyluridine.
um 2′-O-methyluridine.
yw wybutosine.
x 3-(3-amino-3-carboxy-propyl)uridine, (acp3)u.
[86 FR 57052, Oct. 14, 2021]